7R7P

Immature HIV-1 CACTD-SP1 lattice with Bevirimat (BVM) and Inositol hexakisphosphate (IP6)

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D CORD 10 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
2	2D CORD 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
3	2D CORD 50 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
4	2D CORD 100 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
5	2D CORD 200 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
6	2D CORD 10 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	263.15	Bruker AVANCE III 850
7	2D CORD 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	263.15	Bruker AVANCE III 850
8	2D CORD 100 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	263.15	Bruker AVANCE III 850
9	2D CORD 200 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	263.15	Bruker AVANCE III 850
10	2D NCACX 50 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
11	2D NCACX 50 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	263.15	Bruker AVANCE III 850
12	2D CORD 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
13	2D CORD 100 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
14	2D CORD 250 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
15	2D CORD 500 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
16	2D direct INADEQUATE	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
17	2D PAIN CP	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM BVM	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
18	2D CORD 50 ms	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	268.15	Bruker AVANCE III 850
19	2D HC CP HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
20	2D doubleREDOR HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
21	2D hNH HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
22	2D hPH HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
23	1D 31P direct polarization	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
24	1D 31P cross polarization	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
25	1D doubleREDOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6, 360 uM Bevirimat	protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	850
2	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	5
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	magic angle spinning

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	NMRFAM-SPARKY	3.115	Lee, Tonelli and Markley
4	chemical shift assignment	CcpNmr Analysis	2.4	CCPN
5	data analysis	NMRFAM-SPARKY	3.115	Lee, Tonelli and Markley
6	structure calculation	TALOS-N		Shen and Bax
7	structure calculation	X-PLOR NIH	2.53	Schwieters, Kuszewski, Tjandra and Clore
8	refinement	X-PLOR NIH	2.53	Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

7R7P

Immature HIV-1 CACTD-SP1 lattice with Bevirimat (BVM) and Inositol hexakisphosphate (IP6)